GRNA
|
GreenLight Biosciences Holdings, PBC
|
US
|
NASDAQ
|
GRPH
|
Graphite Bio, Inc.
|
US
|
NASDAQ
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|
HELX
|
Franklin Genomic Advancements ETF
|
US
|
AMEX
|
HILS
|
Hillstream BioPharma, Inc.
|
US
|
NASDAQ
|
HOOK
|
HOOKIPA Pharma Inc.
|
US
|
NASDAQ
|
HOWL
|
Werewolf Therapeutics, Inc.
|
US
|
NASDAQ
|
HYPR
|
Hyperfine, Inc.
|
US
|
NASDAQ
|
IDXG
|
Interpace Diagnostics Group, Inc.
|
US
|
NASDAQ
|
ILMN
|
Illumina, Inc.
|
US
|
NASDAQ
|
IMAB
|
I-Mab
|
US
|
NASDAQ
|
IMNN
|
Imunon, Inc.
|
US
|
NASDAQ
|
INKT
|
MiNK Therapeutics, Inc.
|
US
|
NASDAQ
|
INZY
|
Inozyme Pharma, Inc.
|
US
|
NASDAQ
|
IPSC
|
Century Therapeutics, Inc.
|
US
|
NASDAQ
|
IQV
|
IQVIA Holdings, Inc.
|
US
|
NYSE
|
ITOS
|
iTeos Therapeutics, Inc.
|
US
|
NASDAQ
|
IVVD
|
Invivyd, Inc.
|
US
|
NASDAQ
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|